SPECIAL NOTICE
66 -- Defined FBS 500ml
- Notice Date
- 7/7/2016
- Notice Type
- Special Notice
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
- ZIP Code
- 20892-5480
- Solicitation Number
- 16012854
- Archive Date
- 7/22/2016
- Point of Contact
- Andre M. Moody, Phone: 3014022677
- E-Mail Address
-
moodya@cc.nih.gov
(moodya@cc.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The Government intends to award a fixed price purchase order to Fisher Scientific, Hanover Park, IL. The Department of Transfusion (DTM) at the National Institutes of Health (NIH) Clinical Center (CC), Bethesda, MD has a requirement to procure the supplies listed below: The Cell Processing Section (CPS) is responsible for the manufacture of human cells and tissue based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Cell processing procedures are tailored to each of the 30 or more different patient-care clinical research protocols supported. Also, regarding Institute research support it: Develops biologics collection and manufacturing processes to support clinical trials Collects, manufacturers and distribute blood components for in vitro research use Collaboration in the design, planning execution and data analysis of clinical studies Collects and manufacturer specialized cellular products to support clinical trials Develops and evaluate assays for clinical application and biologics safety testing and cellular characterization. Description:Defined FBS 500ml Catalog Number:SH3007003 Quantity:100 Unit of Issue:each Additionally, the appropriate accessories, ie., Alpha Mem, AB plasma, HBSS, etc. Fetal bovine serum is used to aid in expanding mesenchymal stromal cells derived from bone marrow, from bone marrow aspirates. Autologous mesenchymal stromal cells are isolated and expanded in cell factories for 3 weeks. Expanded cells are harvested and prepared for direct injection into the myocardium at the time of recipent's surgery for coronary artery bypass graft or transmyocardial revascularization. The Cell Processing Section (CPS) of DTM provides cellular therapeutics to support the treatment of patients in Clinical Center. One of the cellular therapeutics is Bone Marrow Stromal Cells (BMSCs) which demonstrated great potential in treating a lot of diseases. CPS has been manufacturing BMSCs since 2009, and they were used to support multiple clinical trials sponsored by NHLBI, NIAID, and numerous research projects in NHLBI, NCI, NIAID and NIBIB, which are very important for patient care. Especially in a NHLBI sponsored protocol titled Preliminary Assessment of Direct Intra-myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD with Depressed Left Ventricular Function (ClinicalTrials.gov Identifier: NCT01557543), the patients obtained significant improvement after BMSC treatment.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/16012854/listing.html)
- Place of Performance
- Address: National Institutes of Health, 9000 Rockville Pike, Building 10, Room 3C720, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04174635-W 20160709/160707235607-39144f4d9931fe16f3850a5c8f2a80a2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |